February 10, 2020 / 1:18 PM / 9 days ago

BRIEF-Aptorum Group Plans To Submit An IND Submission With FDA For SACT-1 IN H2 2020

Feb 10 (Reuters) - Aptorum Group Ltd:

* APTORUM GROUP LTD - ANNOUNCES POSITIVE DATA & DEVELOPMENT IN RELATION TO ITS REPURPOSED DRUG CANDIDATE, SACT-1, FOR THE TREATMENT OF NEUROBLASTOMA

* APTORUM GROUP LTD - PLANS TO SUBMIT AN IND SUBMISSION WITH FDA FOR SACT-1 IN H2 2020 Source: (bit.ly/3bqOfwE) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below